Top

Indian Journal of Hematology and Blood Transfusion

Published in:

01-12-2016 | Correspondence

Peri-anal Paraneoplastic Pemphigus Heralding the Relapse of Follicular Lymphoma and Its Successful Management by Rituximab: A Short Correspondence

Authors: Ankur Jain, Gaurav Prakash, Ram V. Nampoothiri, Dipankar De, Amanjit Bal, Alka Khadwal, Deepesh Lad, Pankaj Malhotra, Subhash Varma

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2016

Excerpt

Dear Editor, …

Choi Y, Nam KH, Lee JB, Lee JY, Ihm CW, Lee SE et al (2012) Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus. J Dermatol 39:973–981CrossRefPubMed

Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M et al. (1990) Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 323:1729–1735CrossRefPubMed

Nguyen V, Ndoye A, Bassler K, Schultz L, Shields M, Ruben B et al. (2001) Classification, clinical manifestation and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. Arch Dermatol 137:193–206PubMed

Hidalgo I, Martinez F, Grau C, Gil I, Azón A (2012) Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome. Actas Dermosifiliogr 103:244–246CrossRefPubMed

Bialy-Golan A, Brenner S, Anhalt GJ (1996) Paraneoplastic pemphigus: oral involvement as the sole manifestation. Acta Derm Venereol 76:253–254PubMed

Allen CM, Camisa C (2000) Paraneoplastic pemphigus: a review of the literature. Oral Dis 6:208–214CrossRefPubMed

Tilakaratne W, Dissanayake M (2005) Paraneoplastic pemphigus: a case report and review of literature. Oral Dis 11:326–329CrossRefPubMed

Morikawa K, Tsuji T, Yamasaki H, Egashira S, Kaguchi A, Kido M et al (2014) Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma. Acta Haematol 132:73–74CrossRefPubMed

Hoque SR, Black MM, Cliff S (2007) Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin’s lymphoma treated with rituximab: a third case resistant to Rituximab therapy. Clin Exp Dermatol 32:172–175CrossRefPubMed

Title: Peri-anal Paraneoplastic Pemphigus Heralding the Relapse of Follicular Lymphoma and Its Successful Management by Rituximab: A Short Correspondence
Authors: Ankur Jain
Gaurav Prakash
Ram V. Nampoothiri
Dipankar De
Amanjit Bal
Alka Khadwal
Deepesh Lad
Pankaj Malhotra
Subhash Varma
Publication date: 01-12-2016
Publisher: Springer India
Published in: Indian Journal of Hematology and Blood Transfusion / Issue 4/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-016-0689-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2016

Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation

JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

The Synergistic Effects of Decitabine Combined with Arsenic Trioxide (ATO) in the Human Myelodysplastic Syndrome Cell Line SKM-1

Detection of Hemoglobin New York [β113 (G15) Val→Glu, GTG>GAG] in a Thai Woman by Capillary Electrophoresis

The Interaction Between Niche and Hematopoietic Stem Cells

Clinical Characteristics and Prognostic Factors in Hemophiliacs with Intracranial Hemorrhage: A Single-Center, Retrospective Experience

Keynote webinar | Spotlight on antibody–drug conjugates in cancer